A Simple, Feasible, Efficient and Safe Treatment Strategy of Sofosbuvir/Velpatasvir for Chronic HCV/HIV-1 Coinfected Patients Regardless of HCV Genotypes: A Multicenter, Open-Label Study in China

The 13th Five Year Plan of the Ministry of Science and Technology of China for the prevention and treatment of major infectious diseases such as AIDS and viral hepatitis, the National Key Research and Development Program of China, Medical Key Discipline Program of Guangzhou-Viral Infectious Diseases (2021-2023), Basic research program on people's Livelihood Science and technology of Guangzhou, and National Natural Science Foundation of China.